STOCK TITAN

Diebold Nixdorf (DBD) EVP Zosel receives 6,561 RSU equity award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Zosel Andrew Joseph reported acquisition or exercise transactions in this Form 4 filing.

Diebold Nixdorf EVP and Chief Product & Technology Officer Andrew Joseph Zosel received an equity grant of 6,561 shares of common stock. The award consists of Restricted Stock Units granted under the 2023 Equity and Incentive Plan and vests in three equal annual installments beginning one year from the grant date.

Each Restricted Stock Unit represents a contingent right to receive one share of Diebold Nixdorf common stock. Following this grant, Zosel directly holds 6,561 shares, a figure that includes these Restricted Stock Units.

Positive

  • None.

Negative

  • None.

Insights

Routine RSU grant to senior executive with three-year vesting.

Executive Vice President Andrew Joseph Zosel received 6,561 Restricted Stock Units of Diebold Nixdorf common stock, granted at no cash cost under the 2023 Equity and Incentive Plan. This looks like standard long-term incentive compensation rather than a market transaction.

The RSUs vest in three equal annual installments starting one year from the grant date, creating a multi-year retention and performance alignment mechanism. After the award, Zosel directly holds 6,561 shares, including these RSUs, with no derivative positions disclosed in this filing.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Zosel Andrew Joseph

(Last) (First) (Middle)
C/O DIEBOLD NIXDORF, INCORPORATED
350 ORCHARD AVENUE NE

(Street)
NORTH CANTON OH 44720

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DIEBOLD NIXDORF, Inc [ DBD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, Chief Prod & Tech Officer
3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/01/2026 A 6,561(1) A $0 6,561(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Award of Restricted Stock Units granted under the Diebold Nixdorf, Incorporated 2023 Equity and Incentive Plan, as amended, and vesting in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant; each Restricted Stock Unit represents a contingent right to receive one share of Diebold Nixdorf, Incorporated common stock.
2. Number includes Restricted Stock Units.
Remarks:
/s/ Elizabeth C. Radigan, Attorney-in-fact for Andrew Joseph Zosel 03/17/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Diebold Nixdorf (DBD) executive Andrew Zosel report on this Form 4?

Andrew Joseph Zosel reported receiving 6,561 shares of Diebold Nixdorf common stock through a grant of Restricted Stock Units. The grant was made under the company’s 2023 Equity and Incentive Plan as part of his executive compensation package, not an open-market stock purchase.

How many Diebold Nixdorf (DBD) shares did Andrew Zosel acquire in this transaction?

Andrew Zosel acquired 6,561 shares of Diebold Nixdorf common stock through a grant coded as an award acquisition. These shares are represented by Restricted Stock Units that convert into common stock upon vesting, with no cash price per share shown in the transaction details.

How do Andrew Zosel’s Restricted Stock Units in Diebold Nixdorf (DBD) vest?

Zosel’s Restricted Stock Units vest in three equal annual installments of one-third each, beginning one year from the grant date. This schedule spreads vesting over roughly three years, aligning his equity compensation with longer-term company performance and retention incentives over that period.

What does the transaction code A mean in Andrew Zosel’s Diebold Nixdorf (DBD) Form 4?

Transaction code A on the Form 4 indicates a grant, award, or other acquisition of securities. For Andrew Zosel, it reflects a compensation-related equity award of 6,561 Restricted Stock Units, rather than an open-market purchase or sale of Diebold Nixdorf shares by the executive.

How many Diebold Nixdorf (DBD) shares does Andrew Zosel hold after this RSU grant?

After the reported grant, Andrew Zosel directly holds 6,561 shares of Diebold Nixdorf common stock. This total includes the newly awarded Restricted Stock Units, which each represent a contingent right to receive one share of common stock upon satisfaction of the vesting conditions.

Are Andrew Zosel’s Diebold Nixdorf (DBD) RSUs part of a company equity plan?

Yes. The Restricted Stock Units were granted under the Diebold Nixdorf, Incorporated 2023 Equity and Incentive Plan, as amended. This plan governs how equity awards are made to executives and other participants, including vesting terms and the conversion of units into common stock.
Diebold Nixdorf

NYSE:DBD

View DBD Stock Overview

DBD Rankings

DBD Latest News

DBD Latest SEC Filings

DBD Stock Data

2.51B
34.47M
Software - Application
Calculating & Accounting Machines (no Electronic Computers)
Link
United States
NORTH CANTON